TheraDep
TheraDep is a private life sciences company that uses proprietary Cold Atmospheric Plasma technology to deposit nanometer-thin bioactive coatings on microplates and medical devices for pharmaceutical, biotech, and medical device customers.
- Company typePrivate
- Founded2015
- HeadquartersPalo Alto, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What TheraDep does
TheraDep Technologies, Inc. is a privately held life sciences company founded in 2015, headquartered in Palo Alto, California with European R&D operations in Clonmel, Tipperary, Ireland. The company has developed a proprietary Cold Atmospheric Plasma (CAP) deposition platform branded as BioDep, which covalently bonds bioactive molecules (proteins, peptides, pharmaceuticals, polymers) to virtually any substrate in a single dry step at room temperature, producing nanometer-thin functional coatings without harsh chemicals, heat curing, or polymer binders.
TheraDep monetizes the platform across three product vectors: (1) standardized BioDep Collagen-Coated Microplates in 96-, 384-, and 1536-well formats sold via a direct e-commerce storefront at $164-$400 per case of five plates for life science research and high-throughput screening customers; (2) contract manufacturing and custom coating services where partners supply biologics or substrates to be coated under tailored protocols; and (3) medical device coating solutions covering hydrophilic catheter/guidewire coatings, antimicrobial coatings for metal implants, and drug-eluting coatings for endovascular stents and implants. Pricing for the latter two streams is quote-based and undisclosed. The company is protected by 15+ patents across the US, Europe, Japan, China, and Korea.
The company serves pharmaceutical and biotechnology companies, academic and life science research institutions, and medical device manufacturers through a hybrid GTM combining self-serve e-commerce for SMB customers, enterprise field sales for custom engagements, and a strategic co-development and commercialization partnership with dsm-firmenich Biomedical signed in January 2026 for global scale. A new commercial management team (CEO Bryan Hoadley, COO Dr. Richard Fernandes) was onboarded in 2025 alongside the commercial launch of the BioDep microplate line in February 2026, marking the company's transition from a decade of R&D into active commercialization. The 40M+ procedures claim refers to the underlying medical-grade collagen material's clinical history rather than TheraDep's direct commercial sales.
TheraDep firmographics
Firmographics- Name
- TheraDep
- Legal name
- TheraDep Technologies, Inc.
- Website
- https://theradep.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- TheraDep is a private life sciences company that uses proprietary Cold Atmospheric Plasma technology to deposit nanometer-thin bioactive coatings on microplates and medical devices for pharmaceutical, biotech, and medical device customers.
- Ownership category
- akta.pro rank
TheraDep industry classification
Industry- Product category
- Biomedical Surface Coatings and Coated Labware
- NAICS
- Paint and Coating Manufacturing (32551), Paint, Coating, and Adhesive Manufacturing (3255)
- SIC
- Paints, Varnishes, Lacquers, Enamels & Allied Prods (2851), Laboratory Apparatus & Furniture (3821), Coating, Engraving & Allied Services (3470), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Specialty & Functional Coatings (Anti-microbial/Anti-slip/Insulating) (IMAIAKAM)
- akta.pro secondary industry
- Industrial & Protective Coatings (IMAEAGAB)
Keywords
Where TheraDep is headquartered
LocationHeadquarters
- HQ city
- Palo Alto
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
TheraDep business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Coated Microplate Product Sales: Sale of BioDep medical-grade collagen-coated microplates in 96, 384, and 1536-well formats. Available in clear and black/clear bottom configurations. One-time product purchase with room temperature storage and 24-month shelf life.
- Contract Manufacturing Services: Custom coating services where partners provide biological formulations or plates and TheraDep applies tailored BioDep coatings. Development partnerships for specialized coating solutions.
- Medical Device Coating Solutions: Partnership-based development and coating services for medical device manufacturers including endovascular implants, catheters, guidewires, and orthopedic devices.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | 96-well clear plate - $163.75 per case (5 plates) |
| Unit Pricing | Pay-as-you-go | 96-well black/clear plate - $180.00 per case (5 plates) |
| Unit Pricing | Pay-as-you-go | 384-well clear plate - $191.25 per case (5 plates) |
| Unit Pricing | Pay-as-you-go | 384-well black/clear plate - $283.13 per case (5 plates) |
| Unit Pricing | Pay-as-you-go | 1536-well clear plate - $400.00 per case (5 plates) |
Go-to-market motion4 records
Distribution channels3 records
Marketing channels6 records
TheraDep product offering
Product offeringCore offering
TheraDep manufactures and sells proprietary BioDep Cold Atmospheric Plasma (CAP) coated labware — primarily collagen-coated microplates in 96-, 384-, and 1536-well formats — and provides custom coating services for medical devices, including endovascular implants, catheters, guidewires, and orthopedic implants. The technology covalently bonds bioactive molecules (proteins, peptides, pharmaceuticals) to surfaces in a single dry step at room temperature without harsh chemicals, heat, or binder layers.
Product overview
TheraDep offers a unified platform architecture centered on its proprietary BioDep™ cold atmospheric plasma (CAP) technology. The core technology enables nano-scale bioactive surface coatings applied in a single dry step without harsh chemicals or heat. The primary product line consists of BioDep™ Collagen-Coated Microplates available in 96-well, 384-well, and 1536-well formats (with Clear and Black/Clear bottom variants) for live cell culture and high-throughput screening applications. Supporting sub-brands include BioDep™ Medical Device Coatings (hydrophilic, antimicrobial, and lubricous coatings for catheters, implants, and plastic/ceramic devices) and BioDep™ Endovascular Coatings (drug-eluting coatings for stents and vascular implants). The company also provides contract manufacturing services for custom-coated microplates using their proprietary process.
Differentiator
Problem solved
Functional benefit
Brands
- BioDep: Proprietary bio-surface coating technology platform for medical-grade collagen-coated microplates and bioactive surface coatings using cold plasma deposition.
Products and services
- BioDep Collagen 96-Well Microplate TC-treated polystyrene 96-well microplate coated with uniform nanometer-scale medical-grade collagen for reliable live cell culture (2D & 3D) and high-throughput screening. Available in Clear and Black/Clear bottom formats with flat-bottom geometry optimized for absorbance, fluorescence, and imaging assays.
- BioDep Collagen 384-Well Microplate TC-treated polystyrene 384-well microplate with square-well geometry coated with medical-grade collagen. Designed for live cell culture and high-throughput screening with precision, consistency, and minimal reagent volumes. Optimized for absorbance, fluorescence, and imaging assays.
- BioDep Collagen 1536-Well Microplate TC-treated polystyrene 1536-well microplate with square-well geometry and uniform nanometer-scale medical-grade collagen coating. Designed for ultra-high-throughput screening and miniaturized assays with excellent optical clarity for imaging-based applications.
- BioDep Medical Device Coatings Nanoscale coatings for medical devices including hydrophilic coatings for catheters and guidewires, passive antimicrobial coatings for metal implants, antimicrobial coatings for plastic device components, and surface treatments for ceramic medical parts. Advanced coating technology providing medical devices with superior adhesion and biocompatibility.
- BioDep Endovascular Coatings Drug-eluting coatings and vascular device coatings for stents and endovascular implants. Features improved adhesion during crimping, deployment and expansion, reduced webbing, and elimination of binder layers for optimized localized drug delivery.
- BioDep Assay Coatings (Custom Surface Coatings) Customized surface coatings for labware including collagen, TCT, PDL, ULA, laminin, fibronectin, vitronectin, enzymes, and streptavidin. Cold plasma deposition process covalently bonds pure biologics to surfaces for enhanced assay reproducibility and throughput. Delivered as contract manufacturing services where partners provide formulations or plates and TheraDep applies tailored BioDep coatings.
Quantifiable outcome
- Significant reduction in well-to-well variability compared to commercially available collagen coatings
- +4 more outcomes
Companies that use TheraDep
Customer profileSegments3 records
Ideal customer profiles3 records
TheraDep technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
TheraDep partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- dsm-firmenichcoreStrategic partnership to develop and commercialize advanced bio-surface and nano-coating technologies for life science and medical device applications. Combines TheraDep's proprietary surface deposition platform with dsm-firmenich's biomaterials expertise and leadership in medical-grade biomaterials. Initial product focus on BioDep medical-grade collagen-coated microplates. Joint commitment to product development, material innovation, and scalable manufacturing approaches. Agreement formally signed mid-January 2026 at TheraDep's facility in Tipperary, Ireland.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
TheraDep competitors and assessment
Company assessmentDirect peers
- AST Products: AST Products provides surface modification and thin-film coating services for medical devices, including plasma treatment and biofunctional coatings. It targets the same medical device OEMs as TheraDep's contract coating services, with overlapping capabilities in plasma-based surface engineering.
- Harland Medical Systems: Harland Medical Systems specializes in hydrophilic and antimicrobial coatings for medical devices, offering both coating chemistry and contract coating services to OEMs. It competes directly with TheraDep's medical device coating business in the catheter, guidewire, and implant coating space.
- Polyzen: Polyzen develops specialty polymer coatings and surface treatments for medical devices and pharmaceutical applications, including antimicrobial and biocompatible coatings. It overlaps with TheraDep's medical device coating business in the OEM contract coating space.
- Bio-Techne: Bio-Techne (R&D Systems brand) supplies coated plates, extracellular matrix proteins (collagen, laminin, fibronectin), and assay reagents to the same pharma and academic researchers TheraDep targets. Both sell biologically functionalized surfaces for cell-based assays, though Bio-Techne's catalog is far broader and includes proteins as standalone reagents.
- Surmodics: Surmodics is a leading provider of surface coating technologies for medical devices, including hydrophilic, drug-eluting, and antimicrobial coatings for catheters, guidewires, and implants. TheraDep's BioDep endovascular and antimicrobial implant coatings compete head-to-head with Surmodics' portfolio in the same OEM customer base.
- Biocoat: Biocoat develops hydrophilic and lubricious coatings for medical devices including catheters and guidewires, with both coating chemistry and contract coating services. It is a direct peer in TheraDep's medical device hydrophilic coating application area.
Broad incumbents
- Greiner Bio-One: Greiner Bio-One is a major European manufacturer of microplates, cell culture consumables, and pre-coated assay plates, competing with TheraDep's BioDep microplates in the same pharma/biotech research market. It is a broad incumbent with a much wider catalog and global manufacturing footprint.
- Thermo Fisher Scientific (Lab Products): Thermo Fisher Scientific supplies Nunc and Thermo Scientific branded microplates, coated plates, and cell culture surfaces through its Laboratory Products and Life Sciences segments. It is a broad incumbent competing with TheraDep in coated labware and represents both a competitor and a potential distribution partner for collagen plates.
- Corning Life Sciences: Corning is the dominant global supplier of tissue-culture-treated microplates and cell culture surfaces, directly competing with TheraDep's BioDep collagen microplates in pharma/biotech research labs. Both companies sell coated labware to the same pharmaceutical and academic customers, but Corning operates at much larger scale with an extensive catalog beyond collagen coatings.
Emerging players
- Plasma-Therm: Plasma-Therm manufactures plasma processing equipment used in semiconductor and advanced materials applications. While it serves a different end market, its plasma deposition technology platform overlaps with TheraDep's Cold Atmospheric Plasma heritage, and the company is a potential adjacent technology partner or supplier.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
TheraDep social profiles
Digital presenceTheraDep financial estimates
Financial estimateRevenue estimate
Valuation estimate
TheraDep leadership team
Management profileNumber of profiles
Profiles14 records
TheraDep funding detail
Funding detailFunding overview
Funding rounds3 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TheraDep M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TheraDep
What does TheraDep do?
TheraDep manufactures and sells proprietary BioDep Cold Atmospheric Plasma (CAP) coated labware — primarily collagen-coated microplates in 96-, 384-, and 1536-well formats — and provides custom coating services for medical devices, including endovascular implants, catheters, guidewires, and orthopedic implants. The technology covalently bonds bioactive molecules (proteins, peptides, pharmaceuticals) to surfaces in a single dry step at room temperature without harsh chemicals, heat, or binder layers.
Is TheraDep a public or private company?
TheraDep is a private company. It is classified as venture growth investor backed and is currently operating.
When was TheraDep founded?
TheraDep was founded in 2015. It employs 1 to 10 people.
Where is TheraDep based?
TheraDep is headquartered in Palo Alto, United States, in the North America region.
How does TheraDep make money?
Three revenue lines are on record. Coated Microplate Product Sales are the primary driver. The others are contract Manufacturing Services and medical Device Coating Solutions.
Who are TheraDep's main competitors?
Direct peers on record are AST Products, Harland Medical Systems, Polyzen, Bio-Techne, Surmodics and Biocoat. Broad incumbents are Greiner Bio-One, Thermo Fisher Scientific (Lab Products) and Corning Life Sciences. Plasma-Therm is listed as an emerging player.
Does TheraDep have an API?
No public API is recorded for TheraDep.
What industry is TheraDep in?
TheraDep's product category is Biomedical Surface Coatings and Coated Labware. Its primary akta.pro industry code is IMAIAKAM, Specialty & Functional Coatings (Anti-microbial/Anti-slip/Insulating), with a secondary code of IMAEAGAB, Industrial & Protective Coatings. Its NAICS code is 32551 and its SIC code is 2851.